Innovex International (INVX) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Nov, 2025Executive summary
Achieved $240 million in Q3 2025 revenue, up 58% year-over-year and 7% sequentially, with net income of $39 million and strong market share gains in both North America and international markets, supported by successful Citadel integration and new subsea partnerships.
Free cash flow conversion remained high, with $37 million generated in Q3 and an 83–84% conversion rate from adjusted EBITDA, reflecting a capital-light, resilient model.
Completed major acquisitions (Citadel, SCF, DWS) and the sale of the Eldridge facility, generating $87 million in net proceeds and reducing operational footprint.
Expanded international presence with new manufacturing in Saudi Arabia, growth in Argentina and Asia, and record technology deployment in Abu Dhabi.
Secured exclusive subsea wellhead supply agreement with OneSubsea, opening new long-term growth opportunities.
Financial highlights
Q3 2025 revenue was $240 million, up 58% year-over-year and 7% sequentially; net income was $39 million, with an adjusted EBITDA of $44 million (18% margin).
Free cash flow for Q3 was $37 million; year-to-date free cash flow reached $112 million, with an 83% conversion rate from adjusted EBITDA.
Capital expenditures were $12 million (5% of revenue), with $4 million as one-time integration costs.
Cash and equivalents at quarter-end were $163 million; total debt was $26 million (all finance leases).
Net income margin for Q3 2025 was 16%.
Outlook and guidance
Q4 2025 guidance: adjusted EBITDA of $42–$47 million and revenue of $235–$245 million, assuming flat activity.
Margins expected to remain pressured by integration, tariffs, and product mix, but improvement anticipated in 2026 post-facility consolidation.
Focus remains on organic growth, disciplined acquisitions, and expanding international and offshore market share.
Latest events from Innovex International
- Q4 revenue up 14% sequentially, strong cash flow, and margin expansion expected in 2026.INVX
Q4 202524 Feb 2026 - Q3 revenue up 17% to $152M; $83M net income and $15M synergies highlight merger impact.INVX
Q3 202415 Jan 2026 - Post-merger registration allows resale of 44% of shares, with no proceeds to the company.INVX
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, share increase, LTIP, auditor, and executive pay.INVX
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, share increase, LTIP, auditor, and say-on-pay votes.INVX
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, share increase, incentives, auditor, and pay.INVX
Proxy Filing2 Dec 2025 - Q2 2025 revenue surged 72% YoY to $224.2M, fueled by acquisitions and global expansion.INVX
Q2 20256 Aug 2025 - Revenue up 34% to $120.3M; Innovex merger expected to close in Q3 2024.INVX
Q2 202413 Jun 2025 - Q1 2025 saw strong growth and cash flow, but margins declined amid integration costs.INVX
Q1 20259 Jun 2025